Warning: The NCBI web site requires JavaScript to function. more...
Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour.
Demicheli R, Bonadonna G, Hrushesky WJ, Retsky MW, Valagussa P.
Breast Cancer Res. 2004;6(6):R689-96. Epub 2004 Oct 11.
Related citations
Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy.
Demicheli R, Abbattista A, Miceli R, Valagussa P, Bonadonna G.
Breast Cancer Res Treat. 1996;41(2):177-85.
Double-peaked time distribution of mortality for breast cancer patients undergoing mastectomy.
Demicheli R, Valagussa P, Bonadonna G.
Breast Cancer Res Treat. 2002 Sep;75(2):127-34.
Recurrence dynamics does not depend on the recurrence site.
Demicheli R, Biganzoli E, Boracchi P, Greco M, Retsky MW.
Breast Cancer Res. 2008;10(5):R83. Epub 2008 Oct 9.
Clinical outcomes of post-operative locoregional radiotherapy in pre-menopausal and post-menopausal Chinese women with breast cancer.
Mok TS, Kwan WH, Yeo WM, Chan AT, Chan EC, Chak K, Chow DL, Lo C, Leung TW, Teo PM.
Radiother Oncol. 2000 Mar;54(3):201-8.
Time-varying pattern of recurrence risk for Chinese breast cancer patients.
Yin W, Di G, Zhou L, Lu J, Liu G, Wu J, Shen K, Han Q, Shen Z, Shao Z.
Breast Cancer Res Treat. 2009 Apr;114(3):527-35. Epub 2008 Apr 19.
[Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
Fodor J, Mózsa E, Zaka Z, Polgár C, Major T.
Magy Onkol. 2005;49(3):203, 205-8. Epub 2005 Oct 25. Hungarian.
Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
Rack B, Janni W, Gerber B, Strobl B, Schindlbeck C, Klanner E, Rammel G, Sommer H, Dimpfl T, Friese K.
Breast Cancer Res Treat. 2003 Nov;82(2):83-92.
Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
Lale Atahan I, Yildiz F, Ozyigit G, Sari S, Gurkaynak M, Selek U, Hayran M.
Acta Oncol. 2008;47(2):232-8.
Determinants of axillary recurrence after axillary lymph node dissection for invasive breast cancer.
Voogd AC, de Boer R, van der Sangen MJ, Roumen RM, Rutten HJ, Coebergh JW.
Eur J Surg Oncol. 2001 Apr;27(3):250-5.
Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process.
Demicheli R, Miceli R, Moliterni A, Zambetti M, Hrushesky WJ, Retsky MW, Valagussa P, Bonadonna G.
Ann Oncol. 2005 Sep;16(9):1449-57. Epub 2005 Jun 14.
Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.
Adv Exp Med Biol. 2007;608:1-22. Review.
Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
Bulte CS, van der Heiden-van der Loo M, Hennipman A.
Eur J Surg Oncol. 2009 Jan;35(1):25-31. Epub 2008 Jul 21.
Outpatient follow-up after treatment for early breast cancer: updated results after 5 years.
Churn M, Kelly V.
Clin Oncol (R Coll Radiol). 2001;13(3):187-94.
The correlation between the spread of metastases by level in the axillary nodes and disease-free survival in breast cancer. A multifactorial analysis.
Gaglia P, Bussone R, Caldarola B, Lai M, Jayme A, Caldarola L.
Eur J Cancer Clin Oncol. 1987 Jun;23(6):849-54.
Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E.
Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1337-47.
TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer.
Overgaard J, Yilmaz M, Guldberg P, Hansen LL, Alsner J.
Acta Oncol. 2000;39(3):327-33.
Ten year results of a randomised trial comparing two conservative treatment strategies for small size breast cancer.
Mariani L, Salvadori B, Marubini E, Conti AR, Rovini D, Cusumano F, Rosolin T, Andreola S, Zucali R, Rilke F, Veronesi U.
Eur J Cancer. 1998 Jul;34(8):1156-62.
Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer.
Mansell J, Monypenny IJ, Skene AI, Abram P, Carpenter R, Gattuso JM, Wilson CR, Angerson WJ, Doughty JC.
Breast Cancer Res Treat. 2009 Sep;117(1):91-8. Epub 2008 Dec 27.
Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, Lee JH, Kang SS, Lee JE, Kang MK, Park YJ, Nam HR.
Jpn J Clin Oncol. 2005 Mar;35(3):126-33.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on